ION is honored to broaden our network with Covenant Health,” said Jeffery Goffman, ION’s CEO and co-founder.
Houston, TX (PRWEB) September 08, 2015
“Covenant is proud to announce our relationship with ION to expand access to high-quality oncology services to our community,” said Richard Parks, Covenant Health CEO. “Health care is changing nationally, and Covenant Health is actively evolving to a new care delivery model. In addition to modernizing our hospital facilities and emphasizing prevention and wellness, Covenant is responding to patients’ medical needs by providing more outpatient services and physician offices close to where people live and work. Covenant’s relationship with ION is one more example of our investment in and commitment to the Lubbock community.”
“ION has been focused on expanding our networks across the United States of more than 250 multispecialty oncology-focused physicians to affiliate with larger providers and healthcare systems in their market to provide quality and cost-efficient patient care. ION is honored to broaden our network with Covenant Health,” said Jeffery Goffman, ION’s CEO and co-founder. “The Covenant relationship demonstrates our focus to affiliate and partner with leading hospitals, while maintaining our comprehensive physician network. We will continue to seek such prestigious hospital relationships in all of our markets.”
The radiation facility offers breakthrough technologies, including Intensity-Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT), that offer new hope to individuals who are battling cancer. IMRT is the most technologically advanced and most precise method of external beam radiation therapy available. IGRT takes this technology one step further by delivering high doses of radiation directly to the treatment area while sparing surrounding tissue. Both therapies provide cancer treatment more precisely and with less risk, and both are beneficial for many different types of cancer.
About Covenant Health
Covenant Health is the only integrated health network in the region dedicated to a Christian mission of healing by caring for the whole person – body, mind and spirit – and by working with others to improve health and quality of life in our communities. Covenant Health is the largest, most comprehensive provider in the West Texas and eastern New Mexico region. Celebrating nearly 100 years of excellence, its care network includes more than 5,000 employees and a medical staff of more than 600 physicians; a health plan based in Texas to provide high-quality affordable care; the most advanced, geographically accessible medical group of primary care physicians and specialists; six hospitals with more than 1,000 licensed beds; hospice care and a network of post-acute care providers. Covenant Health is here to help keep people healthy and manage their care, regardless of location on the South Plains. Covenant Health is a member of St. Joseph Health in Orange County; to learn more about this unique ministry of healing visit: http://www.covenanthealth.org or call 1-866-4COVENANT for a physician.
Integrated Oncology Network, LLC and its subsidiaries (“ION” or the “Company”) is a radiation oncology management and cancer center development company that provides oncology solutions for physician practices and hospitals that seek strategic, financial, and management expertise. ION provides compliant solutions for joint ventures, development for cancer centers, financing, and management services with expertise in radiation oncology operations. ION currently has investments in 21 radiation cancer centers in partnership with approximately 250 physicians, and 5 hospital systems. ION is a privately held company whose shareholders include a group of strategic investors, including Capricorn Investment Group and Comvest Group. For more information on ION, please visit our web site at http://www.ion-llc.com.
Statements in this Press Release that are not historical facts constitute “forward-looking statements.” Any statements contained herein which are not historical facts or which contain the words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION’s industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.
CONTACT: Jeffrey Goffman, ION Chairman of the Board and CEO, (949) 207-3111, or
jgoffman(at)ion-llc.com; or, Shelly Biggs, clinical director, Joe Arrington Cancer Center, (806) 725-7930 or sbiggs(at)covhs.org.